title: Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest.
abstract: The recombinant engineering of trisegmented lymphocytic choriomeningitis virus (LCMV) to express two genes of interest was recently reported. We used this technology to efficiently express green fluorescent protein (GFP) and the immunoregulatory gene product interleukin-10 (IL-10) in vitro, assess IL-10 function in vivo during viral meningitis, and generate specific, robust monoclonal antibody responses to IL-10. Tripartite viruses were attenuated in wild-type and TLR7(-/-) mice. However, IFNAR1(-/-) mice sustained systemic viral replication when 2 nucleotide substitutions from a persistent LCMV variant were present. These findings demonstrate the utility of tripartite LCMV in vitro and in vivo to study genes in the context of a well-defined model system.
authors: The Scripps Research Institute, Department of Immunology and Microbial Sciences (IMM-6), 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.
authors: Daniel L
authors: DL
authors: Popkin
authors: John R
authors: JR
authors: Teijaro
authors: Andrew M
authors: AM
authors: Lee
authors: Hanna
authors: H
authors: Lewicki
authors: Sebastien
authors: S
authors: Emonet
authors: Juan Carlos
authors: JC
authors: de la Torre
authors: Michael
authors: M
authors: Oldstone
references: Trends Cell Biol. 1998 Jun;8(6):231-7
references: 9695847
references: Immunol Rev. 2008 Jun;223:114-31
references: 18613832
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3473-8
references: 19208813
references: Nat Immunol. 2007 Apr;8(4):325-7
references: 17375090
references: Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2969-74
references: 21270335
references: Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E57-64
references: 19751403
references: Virology. 2006 Jan 5;344(1):111-8
references: 16364742
references: J Exp Med. 1988 May 1;167(5):1719-24
references: 3367096
references: Cell Host Microbe. 2011 Mar 17;9(3):212-222
references: 21402360
references: Nat Med. 2006 Nov;12(11):1301-9
references: 17041596
references: Immunity. 2006 Sep;25(3):417-28
references: 16973389
references: J Clin Invest. 2004 Mar;113(5):737-45
references: 14991072
references: J Gen Virol. 1995 Feb;76 ( Pt 2):381-91
references: 7531218
references: Genesis. 2000 Nov-Dec;28(3-4):147-55
references: 11105057
references: Virology. 1981 Aug;113(1):73-85
references: 6267791
references: Front Biosci. 2008 May 01;13:4529-43
references: 18508527
references: J Virol. 2009 Oct;83(19):9618-29
references: 19640997
references: Science. 1994 Jun 24;264(5167):1918-21
references: 8009221
references: J Exp Med. 2000 Nov 6;192(9):1249-60
references: 11067874
references: Virology. 2011 Mar 15;411(2):416-25
references: 21324503
references: Curr Top Microbiol Immunol. 2003;276:125-44
references: 12797446